Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages

Journal of Leukocyte Biology

Volumn 60, Issue 3, 1996, Pages 397-404

  Rollo, Ellen E ^a,c   Laskin, Debra L ^a   Denhardt, David T ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Inflammatory response; Mice; Tumor cells

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; OSTEOPONTIN; RECOMBINANT OSTEOPONTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; INFLAMMATION; MACROPHAGE ACTIVATION; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; ESCHERICHIA COLI;

EID: 0029790518     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.3.397     Document Type: Article

References (42)

1. Denhardt, D. T., Guo, X. (1993) Osteopontin, a protein with diverse functions. FASEB J. 7, 1475-1482.
2. Patarca, R., Saavedra, R. A., Cantor, H. (1993) Molecular and cellular basis of genetic resistance to bacterial infection. The role of early T-lymphocyte activation-1/osteopontin gene. Crit. Rev. Immunol. 13, 225-246.
3. Giachelli, C. M., Schwartz, S. M., Liaw, L. (1995) Molecular and cellular biology of osteopontin: Potential role in cardiovascular disease. Trends Cardiovasc. Med. 5, 88-95.
4. McKee, M. D., Nanci, A. (1996) Osteopontin at mineralized tissue interfaces in bone, teeth and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover and repair. Microsc. Res. Tech. 33, 141-164.
5. Patarca, R., Freeman, G. J., Singh, R. P., Wei, F.-Y., Durfee, T., Blattner, F., Regnier, D. C., Kozak, C. A., Mock, B. A., Morse, H. C., III, Jerrells, T. R., Cantor, H. (1989) Structural and functional studies of the early T-lymphocyte activation (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170, 145-161.
6. Miyazaki, Y., Setoguchi, M., Yoshida, S., Higuchi, Y., Akizuki, S., Yamamoto, S. (1990) The mouse osleopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J. Biol. Chem. 265, 14432-14438.
7. Pollack, S. B., Linnemeyer, P. A., Gill, S. (1994) Induction of osteopontin mRNA expression during activation of murine NK cells. J. Leukoc. Biol. 55, 398-400.
8. r (Rickettsia Resistance). Genomics 5, 375-377.
9. Singh, R. P., Patarca, R., Schwartz, J., Singh, P., Cantor, H. (1990) Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J. Exp. Med, 171, 1931-1942.
10. Liaw, L., Almeida, M., Hart, C. E., Schwartz, S. M., Giachelli, C. M. (1994) Osteopontin promotes vascular cell adhesion and apreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 74, 214-224.
11. - lymphocytes during the development of murine autoimmune disease. J. Exp. Med. 172, 1177-1183.
12. Lampe, M. A., Patarca, R., Ireguli, M. V., Cantor, H. (1991) Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J. Immunol. 147, 2902-2906.
13. Senger, D. R., Perruzzi, C. A., Papadoupoulos, A. (1989) Elevated expression of secreted phosphoprotein 1 (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res, 9, 1291-1300.
14. Craig, A. M., Bowden, G. T., Chambers, A. F., Spearman, M. A., Greenberg, A. H., Wright, J. A., McLeod, M., Denhardt, D. T. (1990) Secreted phosphoprotein mRNA is induced during multistage carcinogenesis in mouse skin and correlates with the metastatic potiential of murine fibroblasts. Int. J. Cancer 46, 133-137.
15. Chambers, A. F., Behrend, E. I., Wilson, S. M., Denhardt, D. T. (1992) Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH3T3 cells. Anticancer Res. 12, 43-48.
16. Senger, D. R., Perruzzi, C. A., Gracey, C. F., Papadoupoulos, A., Tenen, D. C. (1988) Secreted phosphoproteins associated with neoplastic transformation: Close homology with plasma proteins cleaved during blood coagulation. Cancer Res. 48, 5770-5774.
17. Behrend, E. I., Craig, A. M., Wilson, S. M., Denhardt, D. T., Chambers, A. F. (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res. 54, 832-837.
18. Gardner, H. A. R., Berse, B., Senger, D. A. (1994) Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 9, 2321-2326.
19. Su, L., Mukherjee, A. B., Mukherjee, B. B. (1995) Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene 10, 2163-2169.
20. Punjabi, C. J., Laskin, D. L, Heck, D. E., Laskin, J. D. (1992) Production of nitric oxide by murine bone marrow cells: Inverse correlation with cellular proliferation. J. Immunol. 149, 2179-2184.
21. Mills, C. D., Shearer, J., Evans, R., Caldwell, M. D. (1992) Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol. 149, 2709-2714.
22. Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H., Russell, S. W. (1993) Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. J. Biol. Chem. 268, 1908-1913.
23. Lavnikova, N., Laskin, D. L. (1993) A single exogenous stimulus activates rat macrophages for nitric oxide production and cytotoxicity. J. Leukoc. Biol. 54, 322-325.
24. Farias-Eisner, R., Sherman, M. P., Aeberhard, E., Chaudhuri, G. (1994) Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA 91, 9407-9411.
25. Hwang, S.-M., Lopez, C. A., Heck, D. E., Gardner, C. R., Laskin, D. L., Laskin, J. D., Denhardt, D. T. (1994) Osteoponlin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem. 269, 711-715.
26. Denhardt, D. T., Chambers, A. F. (1994) Overcoming obstacles to metastasis - defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J. Cell. Biochem. 56, 48-51.
27. Craig, A. M., Smith, J. H., Denhardt, D. T. (1989) Osleopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J. Biol. Chem. 264, 9682-9689.
28. Studier, F. W., Rosenberg, A. H., Dunn, J. J. (1990) Use of T7 RNA polymerase to direct the expression of cloned genes. Meth. Enzmol. 185, 60-89.
29. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Guide, 2nd Ed., Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press.
30. Nasu, K., Ishida, T., Setoguchi, M., Higuchi, Y., Akizuki, S., Yamamoto, S. (1995) Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells. Biochem. J. 307, 257-265.
31. Lyons, C. R., Orloff, G. J., Cunningham, J. M. (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267, 6370-6374.
32. 15N] in biological fluids. Anal. Biochem. 126, 131-144.
33. Rollo, E. E. (1995) Inhibition of Nitric Oxide Production and Macrophage-Mediated Cytotoxicity by Recombinant Human Osteopontin New Brunswick, NJ, Rutgers University, Ph.D. Thesis.
34. Morris, S. M., Billiar, T. R. (1994) New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266, E829-E839.
35. Murata, J.-I., Betz Corradin, S., Janzer, R. C., Juillerat-Jeanneret, L. (1994) Tumor cells suppress cytokine-induced nitric oxide (NO) production in cerebral endothelial cells. Int. J. Cancer 59, 699-705.
36. Feng, B., Rollo, E. E., Denhardt, D. T. (1995) Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage-mediated cytotoxicity: Evidence from cell lines down-regulated for OPN expression by a targeted ribozyme. Clin. Exp. Metastasis 13, 453-462.
37. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Sluehr, D. J., Srimal, S. (1990) Macrophage-deactivating factor and transforming growth factor-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-944.
38. Boutard, V., Havouis, R., Fouqueray, B., Phillippe, C., Moulinoux, J.-P., Baud, L. (1995) Transforming growth factor-β stimulates arginase activity in macrophages. J. Immunol. 155, 2077-2084.
39. Park, E., Schuller-Levis, G., Quinn, M. R. (1995) Taurine chloramine inhibits production of nitric oxide and TNA-α in activated RAS264.7 cells by mechanisms that involve transcriptional and translational events. J. Immunol. 154, 4778-4784.
40. Denhardt, D. T., Lopez, C. A., Rollo, E. E., Hwang, S.-M., An, X.-R., Walther, S. E. (1995) Osteopontin-induced modifications of cellular functions. Ann. NY Acad. Sci. 760, 127.
41. Cui, S., Reichner, J. S., Mateo, R. B., Albina, J. E. (1994) Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54, 2462-2467.
42. Haslett, C., Savill, J. S., Whyte, M. K. B., Stem, M., Dransfield, I., Meagher, L. C. (1994) Granulocyte apoptosis and the control of inflammation. Phil. Trans. Royal Soc. Lond. Ser. B 345, 327-333.